Development of automated patch-clamp technologies for pro-arrhythmogenic risk testing of drugs Transforming the CIPA paradigm into an accurate, efficient, robust and highly reproducible industrial standard for commercialisation and deployment on a broad scale.share on FacebookTwitterLinkedinEmailreport an issue